Our look is new. Our purpose is the same. Learn more about our brand evolution.
[…] patients, industry, research and clinical communities in groundbreaking initiative from Fulcrum Therapeutics Today on World FSHD Day, the FSHD Society and Fulcrum Therapeutics announce the launch of Project Mercury, a […]
The FSHD Society announced the opening today of its FSHD Connect Classroom, the first online, full-day educational conference in the organization’s history. The online conference takes the place of FSHD […]
This Saturday, June 20, 2020, the FSHD Society, the world’s largest research-focused patient organization for facioscapulohumeral muscular dystrophy (FSHD), will be joined by dozens of advocacy groups and allies around […]
[…] MONS, BELGIUM DUX4, the gene that plays a key role in facioscapulohumeral muscular dystrophy ( FSHD), is gaining unexpected notoriety in cancer research. According to a recent study1 from the […]
[…] Society is pleased to announce that it has received a grant of $20,000 from the FSHD Canada Foundation in support of an exciting, treatment-focused project, “Developing LNA-based therapy for facioscapulohumeral […]
